Canopy Growth Corp (CGC) Operating Margin
- Operating margin · 12 months: Value -54.88%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -54.88% | Operating income / revenue. Period ending 2026-06-30. -161.15M ÷ 293.63M × 100 ≈ -54.88% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -161.15M CAD | Operating Income (Loss) |
| Revenue | 293.63M CAD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 219.76M CAD | Cost of Goods and Services Sold |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 162.10M CAD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (CAD) | Revenue (CAD) | Cost of products and services (CAD) | Research and development (CAD) | Selling, general and administration (CAD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | -161.15M | 293.63M | 219.76M | (m) | 162.10M | -54.88% |
| 2026-03-31 | -161.66M | 284.60M | 214.93M | 2.61M | 159.98M | -56.80% |
| 2025-12-31 | -84.14M | 278.39M | 206.44M | (m) | 157.29M | -30.22% |
| 2025-09-30 | -81.61M | 278.61M | 204.02M | (m) | 154.33M | -29.29% |
| 2025-06-30 | -110.66M | 274.92M | 200.40M | (m) | 159.77M | -40.25% |
| 2025-03-31 | -117.14M | 269.00M | 189.48M | 2.74M | 169.63M | -43.55% |
| 2024-12-31 | -205.61M | 276.75M | 192.32M | (m) | 185.79M | -74.29% |
| 2024-09-30 | -242.11M | 280.50M | 191.93M | (m) | 198.75M | -86.31% |
| 2024-06-30 | -203.17M | 287.10M | 196.95M | (m) | 214.63M | -70.77% |
| 2024-03-31 | -228.71M | 297.15M | 216.26M | 4.61M | 229.43M | -76.97% |
| 2023-12-31 | -884.53M | 362.24M | 401.76M | (m) | 359.61M | -244.18% |
| 2023-09-30 | -936.91M | 368.59M | 431.11M | (m) | 394.78M | -254.19% |
| 2023-06-30 | -1.10B | 405.71M | 498.33M | (m) | 444.06M | -270.44% |
| 2023-03-31 | -2.85B | 402.90M | 507.04M | 21.72M | 456.23M | -706.94% |
| 2022-12-31 | -2.70B | 440.96M | 600.22M | (m) | 469.48M | -611.73% |
| 2022-09-30 | -2.69B | 480.72M | 627.44M | (m) | 463.68M | -560.34% |
| 2022-06-30 | -2.73B | 494.23M | 715.91M | (m) | 463.60M | -553.02% |
| 2022-03-31 | -1.08B | 520.33M | 713.38M | 32.34M | 472.76M | -208.08% |
| 2021-12-31 | -786.23M | 556.99M | 581.01M | (m) | 503.83M | -141.16% |
| 2021-09-30 | -1.19B | 568.55M | 578.07M | (m) | 531.07M | -209.28% |
| 2021-06-30 | -1.26B | 572.44M | 484.74M | (m) | 552.57M | -219.90% |
| 2021-03-31 | -1.24B | 546.65M | 479.69M | 57.58M | 575.39M | -227.47% |
| 2020-12-31 | -2.00B | 506.12M | 540.79M | (m) | 624.30M | -395.41% |
| 2020-09-30 | -1.64B | 477.36M | 498.40M | (m) | 649.13M | -343.57% |
| 2020-06-30 | -1.63B | 418.71M | 462.19M | (m) | 683.48M | -388.49% |
| 2020-03-31 | -1.67B | 398.77M | 430.46M | 61.81M | 693.74M | -418.53% |
| 2019-12-31 | (m) | 384.91M | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | 344.19M | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | 290.91M | (m) | (m) | (m) | (m) |
| 2019-03-31 | -637.45M | 226.34M | 198.10M | 15.24M | 392.25M | -281.63% |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | -119.60M | 77.95M | 44.96M | 2.05M | 103.48M | -153.43% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |